HKSE - Delayed Quote HKD

Wai Yuen Tong Medicine Holdings Limited (0897.HK)

0.230 0.000 (0.00%)
At close: 10:08 AM GMT+8
Loading Chart for 0897.HK
DELL
  • Previous Close 0.230
  • Open 0.230
  • Bid 0.226 x --
  • Ask 0.241 x --
  • Day's Range 0.230 - 0.230
  • 52 Week Range 0.100 - 0.460
  • Volume 40,000
  • Avg. Volume 3,218,421
  • Market Cap (intraday) 258.773M
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 7.67
  • EPS (TTM) 0.030
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jul 21, 2014
  • 1y Target Est --

Wai Yuen Tong Medicine Holdings Limited, an investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong. The company manufactures, processes, and sells traditional Chinese medicines under the brand Wai Yuen Tong brand using selected medicinal materials with traditional prescriptions; and western pharmaceutical and personal care products under the Madame Pearl's and Pearl's brands. It also invests in commercial and industrial premises for rental; and offers management and sale of properties in agricultural produce exchange markets. The company was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong. Wai Yuen Tong Medicine Holdings Limited is a subsidiary of Rich Time Strategy Limited.

www.wyth.net

1,962

Full Time Employees

March 31

Fiscal Year Ends

Related News

Performance Overview: 0897.HK

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0897.HK
42.50%
HANG SENG INDEX
1.39%

1-Year Return

0897.HK
42.50%
HANG SENG INDEX
13.40%

3-Year Return

0897.HK
29.23%
HANG SENG INDEX
40.56%

5-Year Return

0897.HK
8.00%
HANG SENG INDEX
42.01%

Compare To: 0897.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0897.HK

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    258.77M

  • Enterprise Value

    1.39B

  • Trailing P/E

    7.77

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    0.12

  • Enterprise Value/Revenue

    1.02

  • Enterprise Value/EBITDA

    8.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.68%

  • Return on Assets (ttm)

    1.04%

  • Return on Equity (ttm)

    1.71%

  • Revenue (ttm)

    1.36B

  • Net Income Avi to Common (ttm)

    36.42M

  • Diluted EPS (ttm)

    0.030

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    500.81M

  • Total Debt/Equity (mrq)

    46.97%

  • Levered Free Cash Flow (ttm)

    -25.27M

Company Insights: 0897.HK

People Also Watch